MARKETS / NASDAQ / LAKE
NASDAQ · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · MID CAP

Lakeland Industries, Inc. LAKE

16 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$192.6M
▲ 15.2% vs FY2024
EPS · FY25
$-2.63
Dividend / sh · FY25
Payout · FY25
-5%
ROE · FY25
-18.4%
Net margin · FY25
-13.1%
Dividend coverage
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 192.6M
Revenue, FY2025 · full 16-year series below
Revenue Net income
0.050.10.150.20.2-0.0201020132016201920222025
0.050.10.150.20.2-0.02016201920222025

The company lost 13 cents on every revenue dollar this year.

Per share
USD -2.63
Diluted EPS, FY2025
EPS
246-2.63201020132016201920222025
246-2.632016201920222025

The company pays no cash dividend.

Profitability
-18.4%
Return on equity, FY2025
ROE
10203040-18.4%201020132016201920222025
10203040-18.4%2016201920222025
Operating margin-8.1%
Net margin-13.1%
Return on assets-12.0%

Each USD of equity lost 18 cents this year.

Returned to shareholders
USD 1.2M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 1.2M
Net buybacks
Share of profit-4.6%
Consecutive raises

USD 1.2M in dividends went back to shareholders in a year without profit.

Growth
+3.9% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+19.5%
+3.9%
+6.8%
+4.5%
Returned to shareholders
−2.4%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.01B
Shares outstanding, FY2025
0.010.01201020132016201920222025
0.010.012016201920222025
Change, 5 years+22.8%
Change, 10 years+35.2%

The share count grew 23% in five years — the same company, cut into more, smaller slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 209.9M
total assets, end of FY2025
Total assetsUSD 209.9M
EquityUSD 129.1M
CashUSD 12.5M
Gross debtUSD 32.3M
Net debtUSD 19.8M
Current ratio3.53×

Net debt stands at 15% of equity.

History
16 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Revenue $B
0.2
0.2
0.1
0.1
0.1
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
Operating income $B
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
0.0
0.0
EBITDA $B
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Income tax $B
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
0.0
−0.0
0.0
Net income $B
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
−0.0
0.0
EPS, diluted $
−2.63
−2.43
0.72
0.24
1.41
4.34
0.41
0.18
0.06
0.53
0.53
1.33
−0.02
−4.97
−0.07
0.18
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
−5
−5
17
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−18.4
−13.4
4.5
1.5
9.2
34.2
3.9
1.8
0.6
5.6
5.9
15.6
−0.3
−45.3
−0.5
1.3
Shares out B
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
·

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
64 of 64
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed